(PM) Philip Morris International - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7181721090
Cigarettes, Heat-Not-Burn, Vapor, Oral Nicotine, Wellness
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.48% |
| Yield on Cost 5y | 8.40% |
| Yield CAGR 5y | 2.83% |
| Payout Consistency | 99.1% |
| Payout Ratio | 74.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 24.5% |
| Value at Risk 5%th | 38.5% |
| Relative Tail Risk | -4.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.99 |
| Alpha | 24.93 |
| CAGR/Max DD | 1.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.405 |
| Beta | 0.099 |
| Beta Downside | 0.259 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.64% |
| Mean DD | 5.83% |
| Median DD | 5.36% |
Description: PM Philip Morris International December 02, 2025
Philip Morris International Inc. (PM) is a global tobacco firm that sells traditional cigarettes and a growing portfolio of smoke-free products-including heat-not-burn IQOS, vapor devices, and oral nicotine ZYN-alongside consumer accessories and emerging wellness offerings. The company, incorporated in 1987, is headquartered in Stamford, Connecticut.
Key metrics highlight the transition to reduced-risk products: FY 2023 net revenue reached roughly $29.5 billion, with smoke-free offerings accounting for about 20 % of total sales and posting double-digit growth year-over-year. IQOS holds an estimated 30 % market share in Japan, the world’s largest reduced-risk market, while ZYN has become the leading oral nicotine brand in the United States, driving a ~15 % increase in U.S. revenue. The sector faces headwinds from declining smoking prevalence and tightening regulations, but the shift toward nicotine-delivery alternatives is a primary growth catalyst.
For a deeper quantitative dive into PM’s valuation dynamics, the ValueRay platform offers a concise, data-driven dashboard worth checking out.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (8.61b TTM) > 0 and > 6% of Revenue (6% = 2.40b TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 0.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 36.17% (prev -6.91%; Δ 43.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 11.53b > Net Income 8.61b (YES >=105%, WARN >=100%) |
| Net Debt (46.05b) to EBITDA (17.68b) ratio: 2.60 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.56b) change vs 12m ago 0.13% (target <= -2.0% for YES) |
| Gross Margin 66.27% (prev 64.18%; Δ 2.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 59.63% (prev 55.64%; Δ 3.99pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.18 (EBITDA TTM 17.68b / Interest Expense TTM 1.92b) >= 6 (WARN >= 3) |
Altman Z'' 2.85
| (A) 0.22 = (Total Current Assets 22.66b - Total Current Liabilities 8.22b) / Total Assets 67.06b |
| (B) -0.02 = Retained Earnings (Balance) -1.56b / Total Assets 67.06b |
| (C) 0.23 = EBIT TTM 15.69b / Avg Total Assets 66.98b |
| (D) -0.06 = Book Value of Equity -4.68b / Total Liabilities 76.05b |
| Total Rating: 2.85 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.06
| 1. Piotroski 7.0pt |
| 2. FCF Yield 3.63% |
| 3. FCF Margin 25.35% |
| 4. Debt/Equity -4.59 |
| 5. Debt/Ebitda 2.60 |
| 6. ROIC - WACC (= 29.03)% |
| 7. RoE -75.66% |
| 8. Rev. Trend 93.19% |
| 9. EPS Trend 71.25% |
What is the price of PM shares?
As of December 18, 2025, the stock is trading at USD 158.61 with a total of 7,113,356 shares traded.
Over the past week, the price has changed by +5.90%, over one month by +3.83%, over three months by -3.73% and over the past year by +30.54%.
Over the past week, the price has changed by +5.90%, over one month by +3.83%, over three months by -3.73% and over the past year by +30.54%.
Is PM a buy, sell or hold?
Philip Morris International has received a consensus analysts rating of 4.06.
Therefore, it is recommended to buy PM.
- Strong Buy: 7
- Buy: 5
- Hold: 4
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the PM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 182.9 | 15.3% |
| Analysts Target Price | 182.9 | 15.3% |
| ValueRay Target Price | 186.3 | 17.5% |
PM Fundamental Data Overview December 12, 2025
Market Cap USD = 233.14b (233.14b USD * 1.0 USD.USD)
P/E Trailing = 21.3652
P/E Forward = 17.9533
P/S = 5.8296
P/EG = 0.9811
Beta = 0.436
Revenue TTM = 39.94b USD
EBIT TTM = 15.69b USD
EBITDA TTM = 17.68b USD
Long Term Debt = 41.86b USD (from longTermDebt, last quarter)
Short Term Debt = 2.74b USD (from shortTermDebt, last quarter)
Debt = 50.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 46.05b USD (from netDebt column, last quarter)
Enterprise Value = 279.18b USD (233.14b + Debt 50.08b - CCE 4.04b)
Interest Coverage Ratio = 8.18 (Ebit TTM 15.69b / Interest Expense TTM 1.92b)
FCF Yield = 3.63% (FCF TTM 10.12b / Enterprise Value 279.18b)
FCF Margin = 25.35% (FCF TTM 10.12b / Revenue TTM 39.94b)
Net Margin = 21.56% (Net Income TTM 8.61b / Revenue TTM 39.94b)
Gross Margin = 66.27% ((Revenue TTM 39.94b - Cost of Revenue TTM 13.47b) / Revenue TTM)
Gross Margin QoQ = 67.85% (prev 67.66%)
Tobins Q-Ratio = 4.16 (Enterprise Value 279.18b / Total Assets 67.06b)
Interest Expense / Debt = 0.46% (Interest Expense 230.0m / Debt 50.08b)
Taxrate = 17.21% (751.0m / 4.36b)
NOPAT = 12.99b (EBIT 15.69b * (1 - 17.21%))
Current Ratio = 2.76 (Total Current Assets 22.66b / Total Current Liabilities 8.22b)
Debt / Equity = -4.59 (negative equity) (Debt 50.08b / totalStockholderEquity, last quarter -10.91b)
Debt / EBITDA = 2.60 (Net Debt 46.05b / EBITDA 17.68b)
Debt / FCF = 4.55 (Net Debt 46.05b / FCF TTM 10.12b)
Total Stockholder Equity = -11.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.84% (Net Income 8.61b / Total Assets 67.06b)
RoE = -75.66% (negative equity) (Net Income TTM 8.61b / Total Stockholder Equity -11.38b)
RoCE = 51.48% (EBIT 15.69b / Capital Employed (Equity -11.38b + L.T.Debt 41.86b))
RoIC = 34.35% (NOPAT 12.99b / Invested Capital 37.82b)
WACC = 5.32% (E(233.14b)/V(283.22b) * Re(6.38%) + D(50.08b)/V(283.22b) * Rd(0.46%) * (1-Tc(0.17)))
Discount Rate = 6.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.13%
[DCF Debug] Terminal Value 77.70% ; FCFE base≈10.09b ; Y1≈9.70b ; Y5≈9.51b
Fair Price DCF = 108.9 (DCF Value 169.53b / Shares Outstanding 1.56b; 5y FCF grow -5.18% → 3.0% )
EPS Correlation: 71.25 | EPS CAGR: 14.46% | SUE: 2.38 | # QB: 1
Revenue Correlation: 93.19 | Revenue CAGR: 8.08% | SUE: 1.05 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.90 | Chg30d=-0.003 | Revisions Net=-1 | Analysts=7
EPS next Year (2026-12-31): EPS=8.34 | Chg30d=-0.014 | Revisions Net=-2 | Growth EPS=+10.4% | Growth Revenue=+7.7%
P/E Trailing = 21.3652
P/E Forward = 17.9533
P/S = 5.8296
P/EG = 0.9811
Beta = 0.436
Revenue TTM = 39.94b USD
EBIT TTM = 15.69b USD
EBITDA TTM = 17.68b USD
Long Term Debt = 41.86b USD (from longTermDebt, last quarter)
Short Term Debt = 2.74b USD (from shortTermDebt, last quarter)
Debt = 50.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 46.05b USD (from netDebt column, last quarter)
Enterprise Value = 279.18b USD (233.14b + Debt 50.08b - CCE 4.04b)
Interest Coverage Ratio = 8.18 (Ebit TTM 15.69b / Interest Expense TTM 1.92b)
FCF Yield = 3.63% (FCF TTM 10.12b / Enterprise Value 279.18b)
FCF Margin = 25.35% (FCF TTM 10.12b / Revenue TTM 39.94b)
Net Margin = 21.56% (Net Income TTM 8.61b / Revenue TTM 39.94b)
Gross Margin = 66.27% ((Revenue TTM 39.94b - Cost of Revenue TTM 13.47b) / Revenue TTM)
Gross Margin QoQ = 67.85% (prev 67.66%)
Tobins Q-Ratio = 4.16 (Enterprise Value 279.18b / Total Assets 67.06b)
Interest Expense / Debt = 0.46% (Interest Expense 230.0m / Debt 50.08b)
Taxrate = 17.21% (751.0m / 4.36b)
NOPAT = 12.99b (EBIT 15.69b * (1 - 17.21%))
Current Ratio = 2.76 (Total Current Assets 22.66b / Total Current Liabilities 8.22b)
Debt / Equity = -4.59 (negative equity) (Debt 50.08b / totalStockholderEquity, last quarter -10.91b)
Debt / EBITDA = 2.60 (Net Debt 46.05b / EBITDA 17.68b)
Debt / FCF = 4.55 (Net Debt 46.05b / FCF TTM 10.12b)
Total Stockholder Equity = -11.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.84% (Net Income 8.61b / Total Assets 67.06b)
RoE = -75.66% (negative equity) (Net Income TTM 8.61b / Total Stockholder Equity -11.38b)
RoCE = 51.48% (EBIT 15.69b / Capital Employed (Equity -11.38b + L.T.Debt 41.86b))
RoIC = 34.35% (NOPAT 12.99b / Invested Capital 37.82b)
WACC = 5.32% (E(233.14b)/V(283.22b) * Re(6.38%) + D(50.08b)/V(283.22b) * Rd(0.46%) * (1-Tc(0.17)))
Discount Rate = 6.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.13%
[DCF Debug] Terminal Value 77.70% ; FCFE base≈10.09b ; Y1≈9.70b ; Y5≈9.51b
Fair Price DCF = 108.9 (DCF Value 169.53b / Shares Outstanding 1.56b; 5y FCF grow -5.18% → 3.0% )
EPS Correlation: 71.25 | EPS CAGR: 14.46% | SUE: 2.38 | # QB: 1
Revenue Correlation: 93.19 | Revenue CAGR: 8.08% | SUE: 1.05 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.90 | Chg30d=-0.003 | Revisions Net=-1 | Analysts=7
EPS next Year (2026-12-31): EPS=8.34 | Chg30d=-0.014 | Revisions Net=-2 | Growth EPS=+10.4% | Growth Revenue=+7.7%
Additional Sources for PM Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle